P11142 (HSP7C_HUMAN) Homo sapiens (Human)
Heat shock cognate 71 kDa protein UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
38 Experimental Structures
Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
---|---|---|---|---|---|---|
Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues |
Heteromer Q99933; | 99.74 | 2×TRS; 4×GOL; | |||
Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues |
Heteromer Q99933; | 99.74 | 2×TRS; 3×GOL; | |||
Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues |
Heteromer Q99933; | 100 | 1×ADN; 8×GOL; 1×TRS; | |||
Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues |
Heteromer Q99933; | 100 | 1×TRS; 1×N8Y; 11×GOL; 4×DMS; | |||
Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues |
Heteromer Q99933; | 100 | 9×GOL; 1×UX0; 1×DMS; 1×TRS; 1×MG; | |||
Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues |
Heteromer Q99933; | 100 | 1×CL; 1×Q88; 5×GOL; 1×DMS; 1×TRS; | |||
Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues |
Heteromer Q99933; | 100 | 2×DMS; 7×GOL; 1×ADE; | |||
Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues |
Heteromer Q99933; | 100 | 1×ZVO; 7×GOL; 1×DMS; | |||
Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues |
Heteromer Q99933; | 100 | 1×1LQ; 8×GOL; 2×DMS; 1×TRS; | |||
Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues |
Heteromer Q99933; | 100 | 6×GOL; 1×CWS; 1×TRS; 1×DMS; 1×CL; | |||
Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues |
Heteromer Q99933; | 100 | 1×ZJB; 2×GOL; 1×TRS; 1×CL; | |||
Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues |
Heteromer Q99933; | 100 | 1×JG8; 4×GOL; 1×TRS; 1×DMS; | |||
Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues |
Heteromer Q99933; | 100 | 1×BBW; 1×DMS; | |||
Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues |
Heteromer Q99933; | 100 | 1×5P7; 1×TRS; 2×DMS; 6×GOL; | |||
Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues |
Heteromer Q99933; | 100 | 1×KC7; 1×TRS; 7×GOL; 3×DMS; | |||
Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues |
Heteromer Q99933; | 100 | 1×1SQ; 3×GOL; | |||
Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues |
Heteromer Q99933; | 100 | 2×GDP; 3×GOL; 1×TRS; 1×DMS; | |||
Crystal structure of HSC70/BAG1 in complex with small molecule inhibitor |
Heteromer Q99933; | 100 | 1×3P1; | |||
Crystal Structures of Hsc70/Bag1 in Complex with Small Molecule Inhibitors |
Heteromer Q99933; | 100 | 1×3BH; | |||
Crystal Structures of Hsc70/Bag1 in Complex with Small Molecule Inhibitors |
Heteromer Q99933; | 100 | 1×TRS; 1×CL; 1×3BK; | |||
Crystal structure of HSC70/BAG1 in complex with small molecule inhibitor |
Heteromer Q99933; | 100 | 1×3F5; | |||
Crystal Structures of Hsc70/Bag1 in Complex with Small Molecule Inhibitors |
Heteromer Q99933; | 100 | 1×TRS; 1×3FD; | |||
Crystal Structure of Hsc70/Bag1 in complex with ATP |
Heteromer Q99933; | 100 | 1×ATP; | |||
Crystal Structures of Hsc70/Bag1 in Complex with Small Molecule Inhibitors |
Heteromer Q99933; | 100 | 1×3GO; | |||
Crystal structure of ATBAG1 in complex with HSP70 |
Heteromer Q0WUQ1; | 100 | ||||
Structure of the CHIP-TPR domain in complex with the Hsc70 Lid-Tail domains |
Heteromer Q9UNE7; | 100.0 | ||||
Crystal structure of human Hsp40 Hdj1 peptide-binding domain complexed with a C-terminal peptide of… |
Heteromer P25685; | 100 | ||||
Structure of HOP TPR2A domain in complex with the non-cognate Hsc70 peptide ligand |
Heteromer P31948; | 100 | 1×NI; | |||
Crystal structure of human Hsp40 Hdj1 peptide-binding domain complexed with a C-terminal peptide of… |
Heteromer P25685; | 100 | ||||
HSC70 NBD with Na, Cl and glycerol | monomer | 100 | 1×NA; 5×PO4; 1×CL; 1×SO4; 2×GOL; | |||
HSC70 NBD with Mg | monomer | 100 | 3×SO4; 1×MG; 1×CL; 4×GOL; 1×ACT; | |||
HSC70 NBD with PO4, Na, Cl | monomer | 100 | 5×PO4; 1×CL; 1×NA; 2×GOL; | |||
HSC70 NBD with ADP and Mg | monomer | 100 | 1×ADP; 2×MG; 1×PO4; | |||
HSC70 NBD with betaine | monomer | 100 | 1×MG; 2×PO4; 1×BET; 1×ACT; | |||
Crystal structure of Hsc70 ATPase domain in complex with ADP and calcium | monomer | 100 | 1×ACT; 2×CA; 1×ADP; | |||
Disrupted hydrogen bond network impairs ATPase activity in an Hsc70 cysteine mutant | monomer | 99.73 | 1×ADP; 1×MG; 2×GOL; | |||
Disrupted hydrogen bond network impairs ATPase activity in an Hsc70 cysteine mutant | monomer | 99.73 | 1×ANP; 1×MG; | |||
Disrupted hydrogen bond network impairs ATPase activity in an Hsc70 cysteine mutant | monomer | 100 | 1×MG; 1×PO4; 1×ADP; 2×GOL; | |||
6 SWISS-MODEL models
Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
7o6r.1.A | monomer | 0.86 | 1×LZ1; 2×K; 1×TMO; | 99.64 | ||
3c7n.1.B | monomer | 0.80 | 1×MG; | 100.00 | ||
7sqc.391.A | monomer | 0.79 | 75.47 | |||
7kzi.1.A | monomer | 0.74 | 49.25 | |||
2kho.1.A | monomer | 0.72 | 51.27 | |||
7kw7.1.C | monomer | 0.68 | 1×ADP; 1×K; | 85.49 | ||
6 SWISS-MODEL models built on isoform sequence
Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|---|
Isoform 2 | 7o6r.1.A | monomer | 0.87 | 2×K; 1×TMO; | 98.30 | ||
Isoform 2 | 7a4u.1.A | monomer | 0.85 | 68.97 | |||
Isoform 2 | 7kw7.1.C | monomer | 0.84 | 1×ADP; 1×K; | 88.06 | ||
Isoform 2 | 6zmd.1.A | monomer | 0.83 | 2×MG; | 69.40 | ||
Isoform 2 | 3c7n.1.B | monomer | 0.82 | 1×MG; | 98.73 | ||
Isoform 2 | 2kho.1.A | monomer | 0.76 | 52.52 | |||